Lexi Ventures Fund I LP
Open, writing first checksEmerging manager
Open: first sale Jul 2025, per Form D (fund age approximates vintage)
- Vintage
- 2025
- Fund size
- $525K to $10M (Form D)
- Stages
- Seed
- Sectors
- Biotech, Synthetic biology
- Regions
- US
01 · Thesis
Lexi Ventures backs seed-stage US companies engineering DNA, RNA, cells and 'omics, including gene editing, RNA delivery, diagnostics and bio tools for therapeutics and industrial applications.Inferred from the firm's website
02 · Initial check
$5K to $167K (estimated from fund size)
Estimated from Form D: $525K sold of a $10M target
03 · Who to approach
Named on this fund's Form D
- Jonah Proujansky-Bell, Managing Member of the General Partner of the Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideLexi Ventures provides seed funding for US-based companies building around DNA, RNA, Cells, 'Omics.
We back the engineers writing the code of life.
https://www.lexi.vc/
06 · Sources
Last verified: Oct 28, 2026